Arbutus Biopharma Presents Preclinical Data at the 2015 International Meeting on Molecular Biology of Hepatitis B Viruses

By: via Benzinga
Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading therapeutic solutions company focused on developing a cure for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.